Unknown

Dataset Information

0

Nuclear factor kappa B activation in cardiomyocytes by serum of children with obstructive sleep apnea syndrome.


ABSTRACT: Obstructive sleep apnea syndrome (OSA) is associated with cardiovascular morbidity in adults and children. NF?B activity is enhanced in circulating monocytes of adults with OSA, that decreases following positive pressure therapy. OSA children's serum activates NF?B in a cell line. We hypothesized that OSA children's serum can activate NF?B in cardiomyocytes (CM) and effect their viability. In order to explore the role played by NF?B in OSA cardiovascular pathophysiology, rat, mouse and human immortalized CM were exposed to human serum drawn from OSA children and matched controls. Increased expression of NF?B classical subunits p65/p50 as well as major morphological changes occurred in cardiomyocytes following OSA's serum exposure. OSA children's serum induced NF?B activity as measured by p65 nuclear translocation in immortalized human CM and rat cardiomyocytes as well as dense immunostaining of the nucleus. Trypan blue and XTT assays showed that OSA sera induced CM apoptosis. We conclude that NF?B is systemically activated in cardiomyocytes, who also demonstrate decreased viability and contractility following exposure to OSA serum. It supports the hypothesis NF?B plays a role in the evolution of cardiovascular morbidity in OSA. It may support the search for new therapeutic interventions controlling NF?B activation in OSA.

SUBMITTER: Goldbart AD 

PROVIDER: S-EPMC7747711 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Nuclear factor kappa B activation in cardiomyocytes by serum of children with obstructive sleep apnea syndrome.

Goldbart Aviv D AD   Gannot Meital M   Haddad Hen H   Gopas Jacob J  

Scientific reports 20201217 1


Obstructive sleep apnea syndrome (OSA) is associated with cardiovascular morbidity in adults and children. NFκB activity is enhanced in circulating monocytes of adults with OSA, that decreases following positive pressure therapy. OSA children's serum activates NFκB in a cell line. We hypothesized that OSA children's serum can activate NFκB in cardiomyocytes (CM) and effect their viability. In order to explore the role played by NFκB in OSA cardiovascular pathophysiology, rat, mouse and human imm  ...[more]

Similar Datasets

| S-EPMC7057627 | biostudies-literature
| S-EPMC8021597 | biostudies-literature
2012-09-01 | E-GEOD-38792 | biostudies-arrayexpress
| S-EPMC4399197 | biostudies-other
| S-EPMC7789821 | biostudies-literature
| S-EPMC10545438 | biostudies-literature
| S-EPMC8584070 | biostudies-literature
2012-09-01 | GSE38792 | GEO
| S-EPMC4563592 | biostudies-literature
| S-EPMC9656345 | biostudies-literature